Tilray Closes a Facility to Reduce Costs, is the Stock a Buy?

: TLRY | Tilray Brands Inc. Cl 2 News, Ratings, and Charts

TLRY – Despite a challenging economic environment, shares of Tilray (TLRY) have rallied almost 500% in just the past two months.

 

Despite a challenging economic environment, shares of Tilray (TLRY) have rallied almost 500% in just the past two months.

Yet, we believe this rally is questionable. 

On May 11th, 2020, TLRY reported a first-quarter net loss of $184.1 million, which amounts to $1.73 a share, compared with a loss of $29.4 million, or 31 cents a share, a year ago. 

However, this week TLRY did take a positive step to reign in their cash burn.

The company announced it will be closing its High Park Gardens facility which is a licensed cannabis greenhouse located in Leamington, Ontario. The closure of the facility is expected to yield $7.5 million in annual savings. High Park Gardens plans to shut down over the next six weeks.  This is part of TLRY’s global cost-efficiency and restructuring plan to finally achieve profitability. 

Brendan Kennedy, Tilray CEO said, “We are continuously evaluating the evolving needs of our business, against a challenging industry backdrop, to ensure we’re in the best position to produce world-class products and deliver positive results for our stakeholders. We are very confident our existing operations team will continue to serve our valued patients and customers with no interruption. On behalf of myself, the rest of our executive team, and our colleagues across the organization, I’d like to extend my sincere gratitude to the team at High Park Gardens for their contributions to Tilray and High Park. The decision to close a facility is never easy but we are confident that this will immediately put Tilray in a better position to achieve our goals of driving revenues across our core businesses and working towards positive adjusted EBITDA by the end of 2020. We are very confident our existing operations team will continue to serve our valued patients and customers with no interruption. On behalf of myself, the rest of our executive team, and our colleagues across the organization, I’d like to extend my sincere gratitude to the team at High Park Gardens for their contributions to Tilray and High Park.”

Their High Park Farms and High Park London facilities remain open and the core driver for the company’s growth plan when addressing the Canadian legal cannabis market.

Shutting down High Park Gardens shows how aggressively the large-cap licensed producers have been forced to scale back operations, cut expenses, and readjust to the current market. 

Though this closure is a step in the right direction, it’s our belief that TLRY isn’t out of the woods by a long shot.  In 2019 the company lost $321.2 million and burned through $258.1 million in cash from its day-to-day operating activities.  Presently, TLRY has only $96.8 million cash on their books.  So investors, please tread cautiously in this stock. 

 

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

Beware 3,000 on S&P?

7 “Safe-Haven” Dividend Stocks for Turbulent Times


TLRY shares were trading at $10.57 per share on Thursday afternoon, down $0.08 (-0.75%). Year-to-date, TLRY has declined -38.30%, versus a -4.37% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
TLRYGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Should Investors BEWARE this Market?

The S&P 500 (SPY) has been on a tear since November 1st when the Fed started to make their dovish tilt opening the door to future rate cuts. Unfortunately they keep not happening and start date keeps getting pushed further and further out. That has many wondering if stocks are getting ahead of themselves setting things up for a fall. Thus a good time to tune into what investment veteran Steve Reitmeister has to say about the market outlook along with his trading plan and top picks to stay ahead of the pack. Read on below for more...

Top 4 Tech Giants Poised for Explosive Growth

Fueled by the ever-growing demand for advanced technological solutions across various sectors and ongoing innovation, the tech industry has robust growth prospects. Thus, it could be wise to invest in top tech stocks Dropbox (DBX), TTM Technologies (TTMI), Lantronix (LTRX) and AstroNova (ALOT) for potential growth. Continue reading…

3 Top Rated Software Stocks to Streamline Your Investments

The software industry is thriving with soaring demand, presenting ample investment opportunities. So, fundamentally solid software stocks ServiceNow (NOW), Autodesk (ADSK), and Docebo (DCBO) might be ideal buys for promising returns. Read on...

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading...

Is the Bull Market Growing Tired?

On the one hand it is fun to celebrate the new highs for the S&P 500 (SPY) that came in this Tuesday. On the other hand...it doesn’t make a lot of sense calling into question the next moves for the stock market. Read on below to appreciate investment veteran, Steve Reitmeister’s, market outlook and top picks to outperform.

Read More Stories

More Tilray Brands Inc. Cl 2 (TLRY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TLRY News